The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.
Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (9)
- The New Mexico Medical Psilocybin Act and current trends in the United States psychedelic policy 2026-10-01 · Expand citations
- BROAD SPECTRUM OF THERAPEUTIC PROPERTIES OF PSILOCYBIN: A LITERATURE REVIEW 2025-02-20 · Expand citations
- Salience, sensemaking, and setting in psilocybin microdosing: Methodological lessons and preliminary findings of a mixed method qualitative study 2024-09-26 · Expand citations
- The potential of psilocybin use to enhance well-being in healthy individuals - A scoping review 2023-11-29 · Expand citations
- Psilocybin's Emerging Role in Combating Depressive Disorder 2023-08-08 · Expand citations
- The right to privacy in the decriminalisation of psilocybin mushrooms in South Africa 2023-01-01 · Expand citations
- The psychedelic renaissance: can psilocybin possibly combat depression? 2022-11-01 · Expand citations
- Psychedelics in the Treatment of Substance Use Disorders 2022-09-01 · Expand citations
- Applying Lessons From Cannabis to the Psychedelic Highway 2022-06-17 · Expand citations